2008
DOI: 10.1016/j.arr.2008.02.001
|View full text |Cite
|
Sign up to set email alerts
|

Cyclin-dependent kinase inhibitor p16INK4a and telomerase may co-modulate endothelial progenitor cells senescence

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
38
0

Year Published

2009
2009
2018
2018

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 48 publications
(38 citation statements)
references
References 85 publications
0
38
0
Order By: Relevance
“…Our data also showed that shikonin increased expression of p16, further contributing to inhibition of phosphorylation of Rb in both K1 and FTC133 cells, and NAC dramatically abolished this effect. These observations suggest that shikonin inhibits cell growth by modulating the activity of the p16/Rb/E2 factor (E2F) pathway, as supported by previous studies showing that ROS-induced upregulation of p16 is one of the mechanisms regulating senescence, which keeps the balance between regeneration and cancer (34,35). Given that metastasis is the major cause of cancer-related death, we investigated the effect of shikonin on cell migration and invasion in this study.…”
Section: Discussionmentioning
confidence: 70%
“…Our data also showed that shikonin increased expression of p16, further contributing to inhibition of phosphorylation of Rb in both K1 and FTC133 cells, and NAC dramatically abolished this effect. These observations suggest that shikonin inhibits cell growth by modulating the activity of the p16/Rb/E2 factor (E2F) pathway, as supported by previous studies showing that ROS-induced upregulation of p16 is one of the mechanisms regulating senescence, which keeps the balance between regeneration and cancer (34,35). Given that metastasis is the major cause of cancer-related death, we investigated the effect of shikonin on cell migration and invasion in this study.…”
Section: Discussionmentioning
confidence: 70%
“…Cellular senescence of endothelial progenitor cells (EPCs), vascular endothelial cells (VECs) and vascular smooth muscle cells (VSMCs) have all been suggested to have causal roles in the development of atherosclerosis (Yang et al, 2008, Minamino et al, 2008, Matthews et al, 2006. This may be due to an impaired ability to replace damaged/lost cells due to senescent EPCs, the reduced proliferative capacity of these tissues owing to the presence of senescent cells, the altered cellular phenotype of the senescent cells, the changed tissue microenvironment of the artery due to the different spectrum of proteins secreted by senescent cells, or a combination of all four.…”
Section: Discussionmentioning
confidence: 99%
“…Many studies have investigated the potential role of cellular senescence in the development and progression of disease, including atherosclerosis (Burton, 2009, Erusalimsky, 2009). Senescence in endothelial progenitor cells (EPCs), vascular endothelial cells (VECs) and vascular smooth muscle cells (VSMCs) have all been implicated in the development and progression of atherosclerosis (Yang et al, 2008, Minamino et al, 2008, Matthews et al, 2006. However, the majority the of work on cellular senescence has been carried out on fibroblasts, with limited understanding of the phenotype of many other cell types, especially those linked to age-related pathology.…”
Section: Introductionmentioning
confidence: 99%
“…Primary diploid cells have limited lifespan before reaching permanent growth arrest called replicative senescence. 42 We here show that onset of replicative senescence in EPCs is delayed compared to HUVECs. However, after 60-80 days of continuous culture, they are also prone to loss of proliferation rate.…”
Section: Discussionmentioning
confidence: 82%